Virginie Le Mabecque
Overview
Explore the profile of Virginie Le Mabecque including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Broquet A, Gourain V, Goronflot T, Le Mabecque V, Sinha D, Ashayeripanah M, et al.
Nat Immunol
. 2024 Oct;
25(11):2167.
PMID: 39375552
No abstract available.
2.
Broquet A, Gourain V, Goronflot T, Le Mabecque V, Sinha D, Ashayeripanah M, et al.
Nat Immunol
. 2024 Apr;
25(5):802-819.
PMID: 38684922
Sepsis induces immune alterations, which last for months after the resolution of illness. The effect of this immunological reprogramming on the risk of developing cancer is unclear. Here we use...
3.
Gaborit B, Roquilly A, Louvet C, Sadek A, Tessoulin B, Broquet A, et al.
J Infect Dis
. 2020 Jul;
222(7):1222-1234.
PMID: 32697326
Sepsis causes inflammation-induced immunosuppression with lymphopenia and alterations of CD4+ T-cell functions that renders the host prone to secondary infections. Whether and how regulatory T cells (Treg) are involved in...
4.
Boudjemaa R, Steenkeste K, Jacqueline C, Briandet R, Caillon J, Boutoille D, et al.
J Antimicrob Chemother
. 2018 Jun;
73(9):2418-2421.
PMID: 29901764
Objectives: To evaluate the significant role played by biofilms during prosthetic vascular material infections (PVMIs). Methods: We developed an in vivo mouse model of Staphylococcus aureus PVMI allowing its direct...
5.
Jacqueline C, Roquilly A, Desessard C, Boutoille D, Broquet A, Le Mabecque V, et al.
J Antimicrob Chemother
. 2012 Sep;
68(1):177-83.
PMID: 22941899
Objectives: To assess the activity of ceftolozane, a novel oxyimino-cephalosporin, in comparison with ceftazidime and piperacillin/tazobactam against a multidrug-resistant Pseudomonas aeruginosa strain using a murine model of pneumonia. Methods: Quantitative...
6.
Bretonniere C, Jacqueline C, Caillon J, Guitton C, Desessard C, Le Mabecque V, et al.
J Antimicrob Chemother
. 2011 Dec;
67(3):780-1.
PMID: 22184470
No abstract available.
7.
Jacqueline C, Amador G, Batard E, Le Mabecque V, Miegeville A, Biek D, et al.
J Antimicrob Chemother
. 2011 Mar;
66(4):863-6.
PMID: 21393213
Objectives: The aim of this study was to compare the in vivo activities of the new antistaphylococcal drugs ceftaroline fosamil, daptomycin and tigecycline at projected human therapeutic doses against methicillin-susceptible...
8.
Bretonniere C, Jacqueline C, Caillon J, Guitton C, Le Mabecque V, Miegeville A, et al.
J Antimicrob Chemother
. 2010 Sep;
65(11):2423-7.
PMID: 20858688
Objectives: The aim of this study was to compare doripenem with imipenem and meropenem in an experimental rabbit model of Pseudomonas aeruginosa pneumonia and then to compare different doripenem doses...
9.
Jacqueline C, Caillon J, Batard E, Le Mabecque V, Amador G, Ge Y, et al.
J Antimicrob Chemother
. 2010 Aug;
65(10):2264-5.
PMID: 20716553
No abstract available.
10.
Jacqueline C, Amador G, Caillon J, Le Mabecque V, Batard E, Miegeville A, et al.
J Antimicrob Chemother
. 2010 Jun;
65(8):1749-52.
PMID: 20530506
Objectives: To evaluate the activity of a new cephalosporin, ceftaroline, in comparison with other antistaphylococcal drugs (linezolid and vancomycin) at projected human therapeutic doses against methicillin-resistant Staphylococcus aureus (MRSA) and...